CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$433M
(+4.8%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
255
Reduced
393
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
